Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:42:16.020Z.
Calculation as of: 2026-10-06T19:42:16.020Z.
Quote observation: 2026-10-06T19:22:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6adff8253f4c85dc5eb0f5c76b7f284768243a99251a0912c87940a98678e1d
PEG RATIO
N/A
Lifeward Ltd.
Market Cap
$10.10M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Lifeward Ltd. (LFWD) | $10.10M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.05M | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.01M | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.23M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.82M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.40M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.77M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.46M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
